Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · IEX Real-Time Price · USD
400.88
-1.26 (-0.31%)
May 2, 2024, 3:15 PM EDT - Market open
Vertex Pharmaceuticals Revenue
In the year 2023, Vertex Pharmaceuticals had annual revenue of $9.87B with 10.51% growth. Revenue in the quarter ending December 31, 2023 was $2.52B with 9.34% year-over-year growth.
Revenue (ttm)
$9.87B
Revenue Growth
+10.51%
P/S Ratio
10.53
Revenue / Employee
$1,827,630
Employees
5,400
Market Cap
103.51B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.87B | 938.50M | 10.51% |
Dec 31, 2022 | 8.93B | 1.36B | 17.91% |
Dec 31, 2021 | 7.57B | 1.37B | 22.06% |
Dec 31, 2020 | 6.21B | 2.04B | 49.08% |
Dec 31, 2019 | 4.16B | 1.12B | 36.59% |
Dec 31, 2018 | 3.05B | 558.95M | 22.46% |
Dec 31, 2017 | 2.49B | 786.48M | 46.20% |
Dec 31, 2016 | 1.70B | 669.84M | 64.89% |
Dec 31, 2015 | 1.03B | 451.92M | 77.86% |
Dec 31, 2014 | 580.42M | -631.56M | -52.11% |
Dec 31, 2013 | 1.21B | -315.07M | -20.63% |
Dec 31, 2012 | 1.53B | 116.42M | 8.25% |
Dec 31, 2011 | 1.41B | 1.27B | 883.91% |
Dec 31, 2010 | 143.37M | 41.48M | 40.71% |
Dec 31, 2009 | 101.89M | -73.62M | -41.94% |
Dec 31, 2008 | 175.50M | -23.51M | -11.81% |
Dec 31, 2007 | 199.01M | -17.34M | -8.02% |
Dec 31, 2006 | 216.36M | 55.47M | 34.47% |
Dec 31, 2005 | 160.89M | 58.17M | 56.63% |
Dec 31, 2004 | 102.72M | 33.58M | 48.56% |
Dec 31, 2003 | 69.14M | -25.63M | -27.04% |
Dec 31, 2002 | 94.77M | 9.47M | 11.11% |
Dec 31, 2001 | 85.30M | -67.99M | -44.35% |
Dec 31, 2000 | 153.28M | 44.40M | 40.77% |
Dec 31, 1999 | 108.89M | 79.83M | 274.76% |
Dec 31, 1998 | 29.06M | -14.74M | -33.66% |
Dec 31, 1997 | 43.80M | 25.20M | 135.50% |
Dec 31, 1996 | 18.60M | -8.94M | -32.45% |
Dec 31, 1995 | 27.53M | 4.39M | 18.96% |
Dec 31, 1994 | 23.15M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 357.78B |
Cigna | 195.27B |
Elevance Health | 171.75B |
Sanofi | 51.60B |
Bristol-Myers Squibb Company | 45.53B |
GSK | 38.39B |
Medtronic | 32.32B |
Stryker | 20.50B |
VRTX News
- 5 days ago - ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN - Business Wire
- 6 days ago - Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older - Business Wire
- 7 days ago - 9 Stocks That Thrive When Interest Rates Are Higher - Barrons
- 9 days ago - VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES - PRNewsWire
- 14 days ago - Vertex's stock climbs as non-opioid pain treatment advances - Market Watch
- 14 days ago - Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain - Business Wire
- 21 days ago - Vertex Pharmaceuticals to Buy Alpine Immune in $4.9B Deal - Barrons
- 21 days ago - Vertex may have to pay more than $65 for Alpine Immune stock ($ALPN) - Invezz